Literature DB >> 2926331

Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line.

K Matsushima1, C G Larsen, G C DuBois, J J Oppenheim.   

Abstract

A novel basic heparin-binding monocyte chemotactic factor (MCF) was purified to homogeneity from the conditioned media of human myelomonocytic cell line THP-1 based on its in vitro monocyte chemotactic activity. The purified MCF was homogenous and estimated to be 15 kD on SDS-PAGE. Purified MCF stimulated normal human monocytes to be growth inhibitory in vitro at 2-3 d for several human tumor cell lines. This represents the first report of the identification and purification of a chemoattractant cytokine that also activates monocytes but is distinct from interferons and other known cytokines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2926331      PMCID: PMC2189236          DOI: 10.1084/jem.169.4.1485

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.

Authors:  J M Schröder; U Mrowietz; E Morita; E Christophers
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

2.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.

Authors:  T Yoshimura; K Matsushima; S Tanaka; E A Robinson; E Appella; J J Oppenheim; E J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes.

Authors:  L C Altman; R Snyderman; J J Oppenheim; S E Mergenhagen
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

4.  Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors.

Authors:  R Snyderman; L C Altman; M S Hausman; S E Mergenhagen
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

5.  Human interleukin 1 is a cytocidal factor for several tumor cell lines.

Authors:  K Onozaki; K Matsushima; B B Aggarwal; J J Oppenheim
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

6.  Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).

Authors:  T Yoshimura; K Matsushima; J J Oppenheim; E J Leonard
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

7.  Purification and biochemical characteristics of two distinct human interleukins 1 from the myelomonocytic THP-1 cell line.

Authors:  K Matsushima; T D Copeland; K Onozaki; J J Oppenheim
Journal:  Biochemistry       Date:  1986-06-03       Impact factor: 3.162

8.  Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.

Authors:  S Heidenreich; M Weyers; J H Gong; H Sprenger; M Nain; D Gemsa
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

9.  Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.

Authors:  K Matsushima; K Morishita; T Yoshimura; S Lavu; Y Kobayashi; W Lew; E Appella; H F Kung; E J Leonard; J J Oppenheim
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

10.  Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.

Authors:  Y Yamaguchi; Y Hayashi; Y Sugama; Y Miura; T Kasahara; S Kitamura; M Torisu; S Mita; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  184 in total

Review 1.  Chemokines. Introduction.

Authors:  K Matsushima
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

3.  Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter.

Authors:  L F Lee; J S Haskill; N Mukaida; K Matsushima; J P Ting
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Ammonium pyrrolidine dithiocarbamate and RS 102895 attenuate opioid withdrawal in vivo and in vitro.

Authors:  Ashish K Rehni; Nirmal Singh
Journal:  Psychopharmacology (Berl)       Date:  2011-09-20       Impact factor: 4.530

5.  Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE.

Authors:  B J Rollins; T Yoshimura; E J Leonard; J S Pober
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

Review 6.  Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.

Authors:  Jian Zhang; Lalit Patel; Kenneth J Pienta
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

7.  Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma.

Authors:  Liping Song; Tasnim Ara; Hong-Wei Wu; Chan-Wook Woo; C Patrick Reynolds; Robert C Seeger; Yves A DeClerck; Carol J Thiele; Richard Sposto; Leonid S Metelitsa
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

8.  Liposome-encapsulated muramyl tripeptide up-regulates monocyte chemotactic and activating factor gene expression in human monocytes at the transcriptional and post-transcriptional levels.

Authors:  T Asano; K Matsushima; E S Kleinerman
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

9.  Primary cilia disruption differentially affects the infiltrating and resident macrophage compartment in the liver.

Authors:  Kurt A Zimmerman; Cheng Jack Song; Nancy Gonzalez-Mize; Zhang Li; Bradley K Yoder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-15       Impact factor: 4.052

10.  Tissue engineering chamber promotes adipose tissue regeneration in adipose tissue engineering models through induced aseptic inflammation.

Authors:  Zhangsong Peng; Ziqing Dong; Qiang Chang; Weiqing Zhan; Zhaowei Zeng; Shengchang Zhang; Feng Lu
Journal:  Tissue Eng Part C Methods       Date:  2014-03-31       Impact factor: 3.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.